久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

Basic Info

  • Grade: Pharmaceutical Grade

    Factory Location: Taizhou, Zhejiang, P.R.China

    Main Sales Markets: Eastern Europe,Asia,Middle East,Africa

  • Monthly Production Capacity: TBC

    Contract Manufacturing: CRO,CMO

  • Sample Provided: no

    Payment Terms: T/T

    For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis；
    Prophylaxis of transplant rejection in adult kidney or liver allograft recipients., , Treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.

    ?

Send your message to this supplier
  • From:
  • To:
    ZHEJIANG HISUN PHARMACEUTICAL CO.,LTD.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    -?Supports?jpg,?jpeg,?png,
    ?gif,?pdf,?doc,?docx,
    ?xls,?xlsx,?txt,?rar?and?zip
    -?Max?upload?3?files;
    ?Max??total?size:?3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service